Evidence map›Paper›PMID 33266342›Full record

ArticleCancers2020

MR Imaging Features to Differentiate Retinoblastoma from Coats' Disease and Persistent Fetal Vasculature.

Robin W Jansen, Christiaan M de Bloeme, Hervé J Brisse, Paolo Galluzzi, Liesbeth Cardoen, Sophia Göricke, Philippe Maeder, Nathalie Cassoux, Arnaud Gauthier, Sabrina Schlueter and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Special Issue ofCancers · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Optic disc and peripapillary tumors.Taiwan journal of ophthalmology
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 5 countries.

Robin W JansenDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081HV Amsterdam, The Netherlands.ORCID 0000-0003-0347-1919
Christiaan M de BloemeDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081HV Amsterdam, The Netherlands.ORCID 0000-0002-4901-0301
Hervé J BrisseDepartment of Radiology, Institut Curie, Paris University, 75005 Paris, France.ORCID 0000-0003-2794-5875
Paolo GalluzziDepartment of Neuroimaging and Neurointervention, Siena University Hospital, 53100 Siena, Italy.
Liesbeth CardoenDepartment of Radiology, Institut Curie, Paris University, 75005 Paris, France.ORCID 0000-0001-7842-8638
Sophia GörickeDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, 45147 Essen, Germany.
Philippe MaederDepartment of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, 1011 Lausanne, Switzerland.
Nathalie CassouxDepartment of Ocular Oncology, Institut Curie, Paris University, 75005 Paris, France.
Arnaud GauthierDepartment of Pathology, Institut Curie, Paris University, 75005 Paris, France.ORCID 0000-0003-3096-6204
Sabrina SchlueterDepartment of Ophthalmology, University Hospital Essen, 45147 Essen, Germany.ORCID 0000-0002-6905-4272
Theodora HadjistilianouDepartment of Ophthalmology, Siena University Hospital, 531000 Siena, Italy.
Francis L MunierDepartment of Ophthalmology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, 1011 Lausanne, Switzerland.
Jonas A CastelijnsDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081HV Amsterdam, The Netherlands.
Paul van der ValkDepartment of Pathology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands.
Annette C MollDepartment of Ophthalmology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands.ORCID 0000-0002-9313-8345
Marcus C de JongDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081HV Amsterdam, The Netherlands.ORCID 0000-0002-8524-5108
Pim de GraafDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, 1081HV Amsterdam, The Netherlands.ORCID 0000-0003-1938-0747
Amsterdam University Medical Centers · NLInstitut Curie · FREssen University Hospital · DEUniversity Hospital of Lausanne · CHUniversity of Siena · IT

Funding

Stichting Kinderen Kankervrij 2018-342
6 · The paper itself

Abstract

Retinoblastoma mimickers, or pseudoretinoblastoma, are conditions that show similarities with the pediatric cancer retinoblastoma. However, false-positive retinoblastoma diagnosis can cause mistreatment, while false-negative diagnosis can cause life-threatening treatment delay. The purpose of this study is to identify the MR imaging features that best differentiate between retinoblastoma and the most common pseudoretinoblastoma diagnoses: Coats' disease and persistent fetal vasculature (PFV). Here, six expert radiologists performed retrospective assessments (blinded for diagnosis) of MR images of patients with a final diagnosis based on histopathology or clinical follow-up. Associations between 20 predefined imaging features and diagnosis were assessed with exact tests corrected for multiple hypothesis testing. Sixty-six patients were included, of which 33 (50%) were retinoblastoma and 33 (50%) pseudoretinoblastoma patients. A larger eye size, vitreous seeding, and sharp-V-shaped retinal detachment were almost exclusively found in retinoblastoma (

Indexed as

Coats’ diseaseMRIpersistent fetal vasculaturepseudoretinoblastomaretinoblastoma

Identifiers

PMID33266342
PMCPMC7760210
OpenAlexW3108452676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.